KAHR medical Funding: $110M Raised, Series A (2020)
KAHR medical is based in Jerusalem, Israel. It has raised $110M in total funding. Latest round: Series A.
KAHR medical funding overview
KAHR medical is based in Jerusalem, Israel. KAHR medical has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2020. The round record for KAHR medical runs through 2020; nothing later has been disclosed. Investors on record include Flerie Invest AB, Oriella Limited, Hadasit Bio-Holdings (HBL), Pavilion Capital, Mirae Asset Venture Investment, DSC Investments and 1 others. 7 distinct backers are named across the disclosed rounds.
KAHR medical has raised $110M in total disclosed funding across the rounds on record.
Who has invested in KAHR medical?
Flerie Invest AB, Oriella Limited, Hadasit Bio-Holdings (HBL), Pavilion Capital, Mirae Asset Venture Investment, DSC Investments are named among the investors backing KAHR medical.
What was the latest KAHR medical funding round?
The most recent disclosed round is a Series A, announced in February 2020.
Where is KAHR medical based?
KAHR medical is based in Jerusalem, Israel.
When did KAHR medical last raise?
The last disclosed KAHR medical round closed in February 2020 at Series A.
Every KAHR medical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Jerusalem at a similar stage.
